Skip to main content
Log in

Admin route for chemo has little impact on QOL

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Kopec JA, Yothers G, Ganz PA, Land SR, Cecchini RS, Wieand HS, Lembersky BC, Wolmark N.Quality of life in operable colon cancer patients receiving oral compared with intravenous chemotherapy: results from National Surgical Adjuvant Breast and Bowel Project Trial C-06. Journal of Clinical Oncology 25: 424-430, No. 4, 1 Feb 2007

  2. Wenzel LB, Huang HQ, Armstrong DK, Walker JL, Cella D.Health-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: a Gynecologic Oncology Group Study. Journal of Clinical Oncology 25: 437-443, No. 4, 1 Feb 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Admin route for chemo has little impact on QOL. Pharmacoecon. Outcomes News 527, 9 (2007). https://doi.org/10.1007/BF03309424

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03309424

Keywords

Navigation